Madrid, Spain

Ana Isabel Rojo SANCHÍS

This inventor holds 1 USPTO granted patent and 1 EPO patent. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ana Isabel Rojo SANCHÍS. Retrieved from https://idiyas.com/inventor/ana-isabel-rojo-sanchis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 1.0

ph-index = 1


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ana Isabel Rojo Sanchís: Research and Patent Activity

Introduction

Ana Isabel Rojo Sanchís is an inventor based in Madrid, Spain. Her patent work concerns NRF2–β-TrCP interaction inhibitors and their potential use in treating liver disease associated with chronic inflammation and oxidative stress.

Latest Patents

The listed patent, “Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the NRF2-β-TrCP interaction for use in the treatment of fatty liver disease,” describes inhibitors of the NRF2–β-TrCP interaction, including derivatives and salts. The invention focuses on their potential application to NRF2-related diseases, particularly fatty liver disease. The provided data lists 1 patent for Rojo Sanchís.

Career Highlights

The organizations associated with Rojo Sanchís’s work include Miguel Hernández University of Elche and the Autonomous University of Madrid. The available information does not specify her roles or dates of affiliation.

Collaborations

Her listed coworkers include José Antonio Encinar and Juan Felipe Franco González. Their names are associated with the research and patent information provided.

Conclusion

Ana Isabel Rojo Sanchís’s listed patent reflects research into a potential therapeutic approach for fatty liver disease by targeting the NRF2–β-TrCP interaction.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…